A Retrospective Analysis of the Efficacy of Low-Dose Metronomic Cyclophosphamide for Treatment in Patients with Low Grade Non-Hodgkin Lymphoma

被引：0
|
作者：
Han, Boram [1 ]
Kim, Bum Jun [1 ]
Kim, Ho Young [1 ]
Zang, Dae Young [2 ]
Lim, Hyun [3 ]
Kang, Ho Suk [1 ]
Soh, Jae Seung [1 ]
Kim, Hyo Jung [4 ]
机构：
[1] Hallym Univ, Med Ctr, Anyang Si, South Korea
[2] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Internal Med, Anyang Si, South Korea
[3] Hallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea
[4] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, South Korea
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149484
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1361
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Low-Dose Radiotherapy for Low Grade Non-Hodgkin Lymphoma of the Orbit
    Wright, Christopher
    Baron, Jonathan
    Lee, Daniel
    Carpenter, Maribel
    Briceno, Cesar
    Chong, Elise
    Maity, Amit
    Plastaras, John
    Paydar, Ima
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S30 - S31
  • [2] Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: A retrospective analysis
    Jung, J. Y.
    Jang, G.
    Song, H.
    Kim, H. S.
    Choi, D. R.
    Kwon, J. H.
    Kim, H. Y.
    Han, B.
    Kim, J. H.
    Kim, H. J.
    Zang, D. Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S114 - S115
  • [3] Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: a retrospective analysis at a single institution
    Jung, Joo Young
    Jang, Geundoo
    Song, Hunho
    Kim, Hyeong Su
    Choi, Dae Ro
    Kwon, Jung Hye
    Kim, Ho Young
    Han, Boram
    Kim, Jung Han
    Kim, Hyo Jung
    Zang, Dae Young
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3893 - 3900
  • [4] CYCLOPHOSPHAMIDE AND METHOTREXATE ORAL COMBINATION CHEMOTHERAPY REGIMEN FOR NON-HODGKIN LYMPHOMA: LOW DOSE METRONOMIC THERAPY
    Kim, H. J.
    Han, B.
    Kang, M. Y.
    Choi, D. R.
    Kim, H. S.
    Kwon, J. H.
    Jang, G.
    Kim, J. H.
    Kim, H. Y.
    Jung, J. Y.
    Song, H. H.
    Zang, D. Y.
    HAEMATOLOGICA, 2012, 97 : 677 - 677
  • [5] High-dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma
    Buckstein, Rena
    Kerbel, Robert S.
    Shaked, Yuval
    Nayar, Rakesh
    Foden, Cindy
    Turner, Ruth
    Lee, Christine R.
    Taylor, Diane
    Zhang, Liying
    Man, Shan
    Baruchel, Sylvain
    Stempak, Diana
    Bertolini, Francesco
    Crump, Michael
    CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5190 - 5198
  • [6] Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma
    Sawyer, EJ
    Timothy, AR
    RADIOTHERAPY AND ONCOLOGY, 1997, 42 (01) : 49 - 51
  • [7] Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma
    Fabbri, Alberto
    Lenoci, Mariapia
    Gozzetti, Alessandro
    Chitarrelli, Ida
    Olcese, Francesca
    Raspadori, Donatella
    Gobbi, Marco
    Lauria, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (01) : 90 - 93
  • [8] Repeated low-dose radiation therapy in indolent Non-Hodgkin Lymphoma patients
    Saleh, K.
    Michot, J. M.
    Schernberg, A.
    Danu, A.
    Lazarovici, J.
    Ghez, D.
    Girinsky, T.
    Khalife-Saleh, N.
    Mazeron, R.
    Ribrag, V.
    Boros, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S690 - S690
  • [9] Low-Dose Radiotherapy in Patients with Non Hodgkin Lymphoma
    Pereira, Dulcineia
    Chacim, Sergio Pereira
    Soares, Andre
    Mesquita, Edgar
    Espirito-Santo, Ana
    Moreira, Ilidia
    Domingues, Nelson
    Oliveira, Isabel
    Viterbo, Luisa
    Marques, Margarida
    Henrique, Rui
    Castro, Carla
    Martins, Angelo
    Oliveira, Angelo
    Mariz, Jose Mario
    BLOOD, 2012, 120 (21)
  • [10] Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas
    Bocchia, M
    Bigazzi, C
    Marconcini, S
    Forconi, F
    Marotta, G
    Algeri, R
    Lauria, F
    HAEMATOLOGICA, 1999, 84 (08) : 716 - 720
12345